{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:02:59Z","timestamp":1790805779578,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What are the pregnancy and obstetric outcomes in women with atypical hyperplasia (AH) or early-stage endometrial cancer (EC) managed conservatively for fertility preservation?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>The study found a live birth rate of 62% in patients with AH or EC after conservative treatment, with higher level of labour induction, caesarean section, and post-partum haemorrhage.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Fertility-sparing treatment is a viable option for women with AH or EC during childbearing years, but the outcomes of such treatments, especially regarding pregnancy and obstetrics, need further exploration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>This retrospective cohort study analysed data from January 2010 to October 2022, involving 269 patients from the French national register of patients with fertility-sparing management of AH\/EC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Women above 18\u2009years of age, previously diagnosed with AH\/EC, and approved for fertility preservation were included. Patients were excluded if they were registered before 2010, if their treatment began &amp;lt;6\u2009months before the study, or if no medical record on the pregnancy was available.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>In total, 95 pregnancies in 67 women were observed. Pregnancy was achieved using ART in 63 cases (66%) and the live birth rate was 62%, with early and late pregnancy loss at 26% and 5%, respectively. In the 59 cases resulting in a live birth, a full-term delivery occurred in 90% of cases; 36% of cases required labour induction and 39% of cases required a caesarean section. The most common maternal complications included gestational diabetes (17%) and post-partum haemorrhaging (20%). The average (\u00b1SD) birthweight was 3110\u2009\u00b1\u2009736 g; there were no significant foetal malformations in the sample. No significant difference was found in pregnancy or obstetric outcomes between ART-obtained and spontaneous pregnancies. However, the incidence of induction of labour, caesarean section, and post-partum haemorrhage appears higher than in the general population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The retrospective nature of the study may introduce bias, and the sample size might be insufficient for assessing rare obstetric complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>This study offers valuable insights for healthcare providers to guide patients who received fertility-sparing treatments for AH\/EC. These pregnancies can be successful and with an acceptable live birth rate, but they seem to be managed with caution, leading to possible tendency for more caesarean sections and labour inductions. No increase in adverse obstetric outcomes was observed, with the exception of suspicion of a higher risk of post-partum haemorrhaging, to be confirmed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>No funding was received for this study. There are no conflicts of interest to declare.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deae089","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T02:59:33Z","timestamp":1715223573000},"page":"1231-1238","source":"Crossref","is-referenced-by-count":13,"title":["Pregnancy and obstetric outcomes after fertility-sparing management of endometrial cancer and atypical hyperplasia: a multicentre cohort study"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6397-1617","authenticated-orcid":false,"given":"Radostina","family":"Vasileva","sequence":"first","affiliation":[{"name":"Department of Obstetrics & Gynecology and Reproductive Medecine, Bichat-Claude Bernard Hospital, AP-HP , Paris, France"},{"name":"Faculty of Medicine, Paris Saclay University , Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Wohrer","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology and Reproductive Medecine, Bichat-Claude Bernard Hospital, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Gaultier","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology and Reproductive Medecine, Bichat-Claude Bernard Hospital, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0904-3336","authenticated-orcid":false,"given":"Margot","family":"Bucau","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Bichat-Claude Bernard Hospital, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Courcier","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology and Reproductive Medecine, Bichat-Claude Bernard Hospital, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selima","family":"Ben Miled","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology and Reproductive Medecine, Bichat-Claude Bernard Hospital, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementine","family":"Gonthier","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology and Reproductive Medecine, Bichat-Claude Bernard Hospital, AP-HP , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Koskas","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynecology and Reproductive Medecine, Bichat-Claude Bernard Hospital, AP-HP , Paris, France"},{"name":"Faculty of Medicine, Paris Cit\u00e9 University , Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"2024060305583214100_deae089-B1","doi-asserted-by":"crossref","first-page":"j1","DOI":"10.1136\/bmj.j1","article-title":"Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child","volume":"356","author":"Catalano","year":"2017","journal-title":"BMJ"},{"key":"2024060305583214100_deae089-B2","author":"Cinelli","year":"2022"},{"key":"2024060305583214100_deae089-B3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","article-title":"Endometrial cancer","volume":"399","author":"Crosbie","year":"2022","journal-title":"Lancet"},{"key":"2024060305583214100_deae089-B4","doi-asserted-by":"crossref","first-page":"hoz038","DOI":"10.1093\/hropen\/hoz038","article-title":"\u201cART in Europe, 2015: results generated from European Registries by ESHRE","volume":"2020","author":"De Geyter","year":"2020","journal-title":"Hum Reprod Open"},{"key":"2024060305583214100_deae089-B5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejogrb.2022.04.019","article-title":"Reproductive and pregnancy outcomes of fertility-sparing treatments for early-stage endometrial cancer or atypical hyperplasia: a systematic review and meta-analysis","volume":"273","author":"De Rocco","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2024060305583214100_deae089-B6","doi-asserted-by":"crossref","first-page":"e52893","DOI":"10.1371\/journal.pone.0052893","article-title":"Incidence and risk factors for placenta accreta\/increta\/percreta in the UK: a national case-control study","volume":"7","author":"Fitzpatrick","year":"2012","journal-title":"PLoS One"},{"key":"2024060305583214100_deae089-B7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/ijgc-2020-001328","article-title":"Fertility preservation in women with early-stage gynecologic cancer: optimizing oncologic and reproductive outcomes","volume":"31","author":"Floyd","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"2024060305583214100_deae089-B8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10815-014-0297-x","article-title":"The outcome of infertility treatment in patients undergoing assisted reproductive technology after conservative therapy for endometrial cancer","volume":"31","author":"Fujimoto","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"2024060305583214100_deae089-B9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ygyno.2013.11.007","article-title":"Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer","volume":"133","author":"Gonthier","year":"2014","journal-title":"Gynecol Oncol"},{"key":"2024060305583214100_deae089-B10","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1093\/humrep\/des251","article-title":"The effect of maternal age on chromosomal anomaly rate and spectrum in recurrent miscarriage","volume":"27","author":"Grande","year":"2012","journal-title":"Hum Reprod"},{"key":"2024060305583214100_deae089-B11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ygyno.2021.01.036","article-title":"Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990\u20132019","volume":"161","author":"Gu","year":"2021","journal-title":"Gynecol Oncol"},{"key":"2024060305583214100_deae089-B12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijgo.12882","article-title":"A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma","volume":"146","author":"Guillon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"2024060305583214100_deae089-B13","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s10815-022-02475-3","article-title":"Analysis of IVF\/ICSI outcomes in infertile women with early-stage endometrial cancer and atypical endometrial hyperplasia after conservative treatment","volume":"39","author":"Guo","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"2024060305583214100_deae089-B14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/humupd\/dmab041","article-title":"Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis","volume":"28","author":"Herrera Cappelletti","year":"2022","journal-title":"Hum Reprod Update"},{"key":"2024060305583214100_deae089-B15","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s10815-022-02606-w","article-title":"Early \u03b2-hCG levels predict live birth after single embryo transfer","volume":"39","author":"Hughes","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"2024060305583214100_deae089-B16","first-page":"104","article-title":"Risk factors for atypical hyperplasia and endometrial cancer in the infertility population: a case-control study","volume":"2","author":"Kahn","year":"2021","journal-title":"F S Rep"},{"key":"2024060305583214100_deae089-B17","first-page":"691","article-title":"Preserving fertility in young patients with endometrial cancer: current perspectives","volume":"6","author":"Kalogera","year":"2014","journal-title":"Int J Womens Health"},{"key":"2024060305583214100_deae089-B18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ijgo.13866","article-title":"Cancer of the corpus uteri: 2021 update","volume":"155 Suppl 1","author":"Koskas","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"2024060305583214100_deae089-B19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","article-title":"Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis","volume":"101","author":"Koskas","year":"2014","journal-title":"Fertil Steril"},{"key":"2024060305583214100_deae089-B20","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/01.AOG.0000255980.88205.15","article-title":"Prognostic factors for uterine cancer in reproductive-aged women","volume":"109","author":"Lee","year":"2007","journal-title":"Obstet Gynecol"},{"key":"2024060305583214100_deae089-B21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.fertnstert.2021.12.025","article-title":"Optimal endometrial thickness in fresh and frozen-thaw in vitro fertilization cycles: an analysis of live birth rates from 96,000 autologous embryo transfers","volume":"117","author":"Mahutte","year":"2022","journal-title":"Fertil Steril"},{"key":"2024060305583214100_deae089-B22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10147-023-02297-y","article-title":"Obstetric outcomes after medroxyprogesterone acetate treatment for early stage endometrial cancer or atypical endometrial hyperplasia: a single hospital-based study","volume":"28","author":"Oishi","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"2024060305583214100_deae089-B23","doi-asserted-by":"crossref","first-page":"S630","DOI":"10.1016\/j.ajog.2018.01.011","article-title":"\u201cThe INTERGROWTH-21st fetal growth standards: toward the global integration of pregnancy and pediatric care","volume":"218","author":"Papageorghiou","year":"2018","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"2024060305583214100_deae089-B24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/AOG.0b013e31827a0643","article-title":"Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer","volume":"121","author":"Park","year":"2013","journal-title":"Obstet Gynecol"},{"key":"2024060305583214100_deae089-B25","doi-asserted-by":"crossref","first-page":"678.e1","DOI":"10.1016\/j.ajog.2009.02.032","article-title":"Incidence of endometrial hyperplasia","volume":"200","author":"Reed","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"2024060305583214100_deae089-B26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2022.01.019","article-title":"Overweight, obesity and assisted reproduction: a systematic review and meta-analysis","volume":"271","author":"Ribeiro","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2024060305583214100_deae089-B27","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/1471-0528.17553","article-title":"Risk of adverse obstetric outcomes in patients with a history of endometrial cancer: a nationwide population-based cohort study","volume":"130","author":"Shim","year":"2023","journal-title":"BJOG"},{"key":"2024060305583214100_deae089-B28","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1093\/humrep\/dead220","article-title":"The impact of previous conservative treatment of atypical hyperplasia on pregnancy outcomes after IVF\/ICSI-embryo transfer: a propensity score-matched retrospective cohort study","volume":"38","author":"Song","year":"2023","journal-title":"Hum Reprod"},{"key":"2024060305583214100_deae089-B29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2024060305583214100_deae089-B30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.rbmo.2021.06.007","article-title":"IVF impact on the risk of recurrence of endometrial adenocarcinoma after fertility-sparing management","volume":"43","author":"Vaugon","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"2024060305583214100_deae089-B31","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.fertnstert.2017.09.014","article-title":"Perinatal outcomes after natural conception versus in vitro fertilization (IVF) in gestational surrogates: a model to evaluate IVF treatment versus maternal effects","volume":"108","author":"Woo","year":"2017","journal-title":"Fertil Steril"},{"key":"2024060305583214100_deae089-B32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/humupd\/dmv066","article-title":"Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers","volume":"22","author":"Zapardiel","year":"2016","journal-title":"Hum Reprod Update"},{"key":"2024060305583214100_deae089-B33","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12884-023-05418-7","article-title":"Obstetric and perinatal outcomes following frozen and fresh embryo transfer in patients with endometrial hyperplasia and carcinoma: a retrospective study in a high-volume reproductive center","volume":"23","author":"Zong","year":"2023","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/6\/1231\/58039875\/deae089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/6\/1231\/58039875\/deae089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T14:47:50Z","timestamp":1717426070000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/39\/6\/1231\/7667384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,5,8]]},"published-print":{"date-parts":[[2024,6,3]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deae089","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6,1]]},"published":{"date-parts":[[2024,5,8]]}}}